Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Faries

Showing results (61-70 of 145) with videos related to

Pageof 15
Sort By:
Acta Oncologica (Stockholm, Sweden)|February 11, 2025
Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II)Pia J Heino, Jukka Pappinen, John F Thompson, et al.
Frontiers in Oncology|September 1, 2017
Prognostic Value of Multiple Draining Lymph Node Basins in Melanoma: A Matched-Pair Analysis Based on the John Wayne Cancer Institute ExperienceJ Harrison Howard, Junko J Ozao-Choy, Jason M Hiles, et al.
Journal of the American College of Surgeons|March 29, 2011
Management of popliteal sentinel nodes in melanomaShawn T Steen, Hamed Kargozaran, Christopher J Moran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanomaJohn C Kang, Leslie A Wanek, Richard Essner, et al.
Cancer Journal (Sudbury, Mass.)|June 29, 2006
Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes?Shawn E Young, Steve R Martinez, Mark B Faries, et al.
The American Surgeon|January 24, 2016
Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five DecadesDaniel D Kirchoff, Gary B Deutsch, Leland J Foshag, et al.
Clinical Nuclear Medicine|December 10, 2003
The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision makingSeza A Gulec, Mark B Faries, Chris C Lee, et al.
Journal of the American Academy of Dermatology|January 16, 2018
Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapyGary B Deutsch, Richard Tyrell, Samuel Yost, et al.
The American Surgeon|November 5, 2009
Does specialized surgical training increase lymph node yield in colon cancer?Michael B Nicholl, Byron E Wright, W Charles Conway, et al.
The American Journal of Dermatopathology|February 4, 2022
Immunohistochemistry for Preferentially Expressed Antigen in Melanoma in the Differential Diagnosis of Melanocytic Lesions of the Nail ApparatusAndrea Krajisnik, Nima M Gharavi, Mark B Faries, et al.
Pageof 15

Showing results (61-70 of 145) with videos related to

Sort By:
Pageof 15
Acta Oncologica (Stockholm, Sweden)|February 11, 2025
Health-related Quality of Life and hospital costs of Finnish melanoma patients participating in the second Multicenter Selective Lymphadenectomy Trial (MSLT-II)Pia J Heino, Jukka Pappinen, John F Thompson, et al.
Frontiers in Oncology|September 1, 2017
Prognostic Value of Multiple Draining Lymph Node Basins in Melanoma: A Matched-Pair Analysis Based on the John Wayne Cancer Institute ExperienceJ Harrison Howard, Junko J Ozao-Choy, Jason M Hiles, et al.
Journal of the American College of Surgeons|March 29, 2011
Management of popliteal sentinel nodes in melanomaShawn T Steen, Hamed Kargozaran, Christopher J Moran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2005
Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanomaJohn C Kang, Leslie A Wanek, Richard Essner, et al.
Cancer Journal (Sudbury, Mass.)|June 29, 2006
Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes?Shawn E Young, Steve R Martinez, Mark B Faries, et al.
The American Surgeon|January 24, 2016
Evolving Therapeutic Strategies in Mucosal Melanoma Have Not Improved Survival Over Five DecadesDaniel D Kirchoff, Gary B Deutsch, Leland J Foshag, et al.
Clinical Nuclear Medicine|December 10, 2003
The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision makingSeza A Gulec, Mark B Faries, Chris C Lee, et al.
Journal of the American Academy of Dermatology|January 16, 2018
Predicting the incidence and timing of central nervous system disease in metastatic melanoma: Implications for surveillance and preventative therapyGary B Deutsch, Richard Tyrell, Samuel Yost, et al.
The American Surgeon|November 5, 2009
Does specialized surgical training increase lymph node yield in colon cancer?Michael B Nicholl, Byron E Wright, W Charles Conway, et al.
The American Journal of Dermatopathology|February 4, 2022
Immunohistochemistry for Preferentially Expressed Antigen in Melanoma in the Differential Diagnosis of Melanocytic Lesions of the Nail ApparatusAndrea Krajisnik, Nima M Gharavi, Mark B Faries, et al.
Pageof 15